December 16, 2013 | Hadasit, the technology transfer company of the Hadassah Medical Center, has signed a $4 million cooperation agreement with Poland’s Synektik SA to develop new imaging agents for non-invasive diagnosis of cardiovascular disease. The imaging agents are for use in PET/ CT scans, enabling physicians to achieve a quantitative measurement of blood flow to the heart.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments